Suchergebnisse - "Bertsch, Uta"

PubPharm (109)

1

Predictors of early morbidity and mortality in newly diagnosed multiple myeloma : data from five randomized, controlled, phase III trials in 3700 patients

enthalten in: Leukemia | 2024

von Mai, E. | Hielscher, T. | Bertsch, U. | +26

2

Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6) : results from a randomised, phase 3 trial

enthalten in: The lancet / Haematology | February 2024

von Mai, E. | Goldschmidt, H. | Miah, K. | +32

3

Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6) : results from a randomised, phase 3 trial

enthalten in: The Lancet. Haematology | 2024

von Mai, E. | Goldschmid, H. | Miah, K. | +74

ErratumIn: Lancet Haematol. 2024 Feb 7;:. - PMID 38340740

4

Identification of novel genetic loci for risk of multiple myeloma by functional annotation

enthalten in: Leukemia | 2023

von Macauda, A. | Briem, K. | Clay-Gilmour, A. | +63

5

Comparison of bone marrow and peripheral blood aberrant plasma cell assessment by NGF in patients with MM

enthalten in: Blood advances | 2023

von Kriegsmann, K. | Manta, C. | Schwab, R. | +17

6

RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma

enthalten in: Frontiers in immunology | 2023

von Emde-Rajaratnam, M. | Beck, S. | Benes, V. | +17

7

Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma

enthalten in: Blood cancer journal | 2023

von Mai, E. | Huhn, S. | Miah, K. | +16

8

Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma

enthalten in: Blood cancer journal | 04 January 2023

von Mai, E. | Huhn, S. | Miah, K. | +16

9

Comparison of bone marrow and peripheral blood aberrant plasma cell assessment by NGF in patients with MM

enthalten in: Blood advances | January 27, 2023

von Kriegsmann, K. | Manta, C. | Schwab, R. | +17

10

Predictors of early morbidity and mortality in newly diagnosed multiple myeloma : data from five randomized, controlled, phase III trials in 3700 patients

enthalten in: Leukemia | 07 December 2023

von Mai, E. | Hielscher, T. | Bertsch, U. | +26

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]